Blog
The Beauty Health Company (SKIN) Reports Q3 Loss, Tops Revenue Estimates
The Beauty Health Company (SKIN) came out with a quarterly loss of $0.09 per share versus the Zacks Consensus Estimate of a loss of $0.08. This compares to a loss of $0.15 per share a year ago
Lifecore Biomedical (LFCR) Reports Q1 Loss, Beats Revenue Estimates
Lifecore Biomedical (LFCR) came out with a quarterly loss of $0.29 per share versus the Zacks Consensus Estimate of a loss of $0.3. This compares to a loss of $0.53 per share a year ago. These
PAR Technology (PAR) Misses Q3 Earnings Estimates
PAR Technology (PAR) came out with quarterly earnings of $0.06 per share, missing the Zacks Consensus Estimate of $0.09 per share. This compares to a loss of $0.09 per share a year ago. These
Onto Innovation (ONTO) Tops Q3 Earnings Estimates
Onto Innovation (ONTO) came out with quarterly earnings of $0.92 per share, beating the Zacks Consensus Estimate of $0.87 per share. This compares to earnings of $1.34 per share a year ago. These
MP Materials Corp. (MP) Reports Q3 Loss, Tops Revenue Estimates
MP Materials Corp. (MP) came out with a quarterly loss of $0.1 per share versus the Zacks Consensus Estimate of a loss of $0.14. This compares to a loss of $0.12 per share a year ago. These figures
Figs (FIGS) Beats Q3 Earnings and Revenue Estimates
Figs (FIGS) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of $0.02 per share. This compares to a loss of $0.01 per share a year ago. These figures are
Huntsman (HUN) Reports Q3 Loss, Tops Revenue Estimates
Huntsman (HUN) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.13. This compares to earnings of $0.1 per share a year ago. These figures are
Zymeworks Inc. (ZYME) Reports Q3 Loss, Lags Revenue Estimates
Zymeworks Inc. (ZYME) came out with a quarterly loss of $0.26 per share versus the Zacks Consensus Estimate of a loss of $0.3. This compares to a loss of $0.39 per share a year ago. These figures
Universal Logistics (ULH) Beats Q3 Earnings Estimates
Universal Logistics (ULH) came out with quarterly earnings of $0.24 per share, beating the Zacks Consensus Estimate of $0.18 per share. This compares to earnings of $1.01 per share a year ago. These
Five9 (FIVN) Tops Q3 Earnings and Revenue Estimates
Five9 (FIVN) came out with quarterly earnings of $0.78 per share, beating the Zacks Consensus Estimate of $0.73 per share. This compares to earnings of $0.67 per share a year ago. These figures are
Microchip Technology (MCHP) Q2 Earnings and Revenues Top Estimates
Microchip Technology (MCHP) came out with quarterly earnings of $0.35 per share, beating the Zacks Consensus Estimate of $0.33 per share. This compares to earnings of $0.46 per share a year ago
Eton Pharmaceuticals, Inc. (ETON) Reports Q3 Loss, Beats Revenue Estimates
Eton Pharmaceuticals, Inc. (ETON) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of $0.13. This compares to earnings of $0.02 per share a year ago. These
BioLife Solutions, Inc. (BLFS) Surpasses Q3 Earnings and Revenue Estimates
BioLife Solutions, Inc. (BLFS) came out with quarterly earnings of $0.04 per share, beating the Zacks Consensus Estimate of a loss of $0.01 per share. This compares to a loss of $0.02 per share a
VTEX (VTEX) Meets Q3 Earnings Estimates
VTEX (VTEX) came out with quarterly earnings of $0.03 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.02 per share a year ago. These figures are adjusted for
EOG Resources (EOG) Surpasses Q3 Earnings Estimates
EOG Resources (EOG) came out with quarterly earnings of $2.71 per share, beating the Zacks Consensus Estimate of $2.43 per share. This compares to earnings of $2.89 per share a year ago. These
Tandem Diabetes Care, Inc. (TNDM) Reports Q3 Loss, Tops Revenue Estimates
Tandem Diabetes Care, Inc. (TNDM) came out with a quarterly loss of $0.31 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.36 per share a year ago. These figures
Camden (CPT) Tops Q3 FFO Estimates
Camden (CPT) came out with quarterly funds from operations (FFO) of $1.7 per share, beating the Zacks Consensus Estimate of $1.69 per share. This compares to FFO of $1.71 per share a year ago. These
Dropbox (DBX) Q3 Earnings and Revenues Beat Estimates
Dropbox (DBX) came out with quarterly earnings of $0.74 per share, beating the Zacks Consensus Estimate of $0.64 per share. This compares to earnings of $0.6 per share a year ago. These figures are
Solventum (SOLV) Surpasses Q3 Earnings and Revenue Estimates
Solventum (SOLV) came out with quarterly earnings of $1.5 per share, beating the Zacks Consensus Estimate of $1.43 per share. This compares to earnings of $1.64 per share a year ago. These figures
Block (XYZ) Misses Q3 Earnings and Revenue Estimates
Block (XYZ) came out with quarterly earnings of $0.54 per share, missing the Zacks Consensus Estimate of $0.63 per share. This compares to earnings of $0.88 per share a year ago. These figures are
Celanese (CE) Beats Q3 Earnings Estimates
Celanese (CE) came out with quarterly earnings of $1.34 per share, beating the Zacks Consensus Estimate of $1.27 per share. This compares to earnings of $2.44 per share a year ago. These figures are
Monster Beverage (MNST) Surpasses Q3 Earnings and Revenue Estimates
Monster Beverage (MNST) came out with quarterly earnings of $0.56 per share, beating the Zacks Consensus Estimate of $0.48 per share. This compares to earnings of $0.4 per share a year ago. These
Doximity (DOCS) Tops Q2 Earnings and Revenue Estimates
Doximity (DOCS) came out with quarterly earnings of $0.45 per share, beating the Zacks Consensus Estimate of $0.38 per share. This compares to earnings of $0.3 per share a year ago. These figures
Akamai Technologies (AKAM) Beats Q3 Earnings and Revenue Estimates
Akamai Technologies (AKAM) came out with quarterly earnings of $1.86 per share, beating the Zacks Consensus Estimate of $1.64 per share. This compares to earnings of $1.59 per share a year ago
Intellia Therapeutics, Inc. (NTLA) Reports Q3 Loss, Misses Revenue Estimates
Intellia Therapeutics, Inc. (NTLA) came out with a quarterly loss of $0.92 per share versus the Zacks Consensus Estimate of a loss of $1.02. This compares to a loss of $1.34 per share a year ago


